Skip to main content
placeholder image

Fgfr Inhibitor and Chemotherapy in Gastric Cancer (Facing): Phase I Results from an Ecmc Combinations Alliance Phase I/II Trial of Azd4547 in Combination with Cisplatin and Capecitabine (Cx)

Journal Article


Abstract


Publication Date


  • 2014

Citation


  • Lindsay, C., Thistlethwaite, F., Gupta, A., Mansoor, W., Lewsley, L., Hubner, R., . . . Evans, T. R. J. (2014). Fgfr Inhibitor and Chemotherapy in Gastric Cancer (Facing): Phase I Results from an Ecmc Combinations Alliance Phase I/II Trial of Azd4547 in Combination with Cisplatin and Capecitabine (Cx). Annals of Oncology, 25, iv155. doi:10.1093/annonc/mdu331.27

Web Of Science Accession Number


Start Page


  • iv155

Volume


  • 25

Abstract


Publication Date


  • 2014

Citation


  • Lindsay, C., Thistlethwaite, F., Gupta, A., Mansoor, W., Lewsley, L., Hubner, R., . . . Evans, T. R. J. (2014). Fgfr Inhibitor and Chemotherapy in Gastric Cancer (Facing): Phase I Results from an Ecmc Combinations Alliance Phase I/II Trial of Azd4547 in Combination with Cisplatin and Capecitabine (Cx). Annals of Oncology, 25, iv155. doi:10.1093/annonc/mdu331.27

Web Of Science Accession Number


Start Page


  • iv155

Volume


  • 25